Ocular Therapeutix Inc. - notizie pubblicate 197 - letture 2.110
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Second Quarter 2024 Results
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)
Table of contents united states securities and exchange commission washington, d.c. 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securitie ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMD
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Bedford, mass., july 18, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul) ("ocular"), a biopharmaceutical company committed to enhancing people's vision an ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Announces Late-Breaking Abstract of HELIOS Study to be Presented at 42nd ASRS Annual Scientific Meeting
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
OCULAR THERAPEUTIX INC.
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer ocular therapeutix inc. published this ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti